250
Views
2
CrossRef citations to date
0
Altmetric
Diagnostic Profile

Profile of GenMark’s ePlex® blood culture identification fungal pathogen panel

, , &
Pages 119-132 | Received 11 Oct 2017, Accepted 19 Dec 2017, Published online: 28 Dec 2017

References

  • LIFE (Leading International Fungal Education) 2017. The burden of fungal disease: new evidence to show the scale of the problem across the globe. Available from: http://www.life-worldwide.org/media-centre/article/the-burden-of-fungal-disease-new-evidence-to-show-the-scale-of-the-problem
  • Brown GD, Denning DW, Gow NAR, et al. Hidden killers: human fungal infections. Sci Transl Med. 2012;4:165rv13.
  • Global Action Fund for Fungal Infections (GAFFI). Improving outcomes for patients with fungal infections across the world: a roadmap for the next decade. 2015; Available from: http://www.gaffi.org/roadmap/.
  • Bassetti M, Peghin M, Timsit J-F. The current treatment landscape: candidiasis. J Antimicrob Chemother. 2016;71:ii13–ii22.
  • Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2016;62:e1–50.
  • Colombo AL, de Almeida Júnior JN, Slavin MA, et al. Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer. Lancet Infect Dis. 2017;17:e344-e356.
  • Bailly S, Garnaud C, Cornet M, et al. Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2016;35:1023–1032.
  • Montravers P, Mira J-P, Gangneux J-P, et al. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2011;17:1061–1067.
  • Cuenca-Estrella M, Verweij PE, Arendrup MC, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2012;18(Suppl 7):9–18.
  • Puig-Asensio M, Pemán J, Zaragoza R, et al. Impact of therapeutic strategies on the prognosis of candidemia in the ICU. Crit Care Med. 2014;42:1423–1432.
  • Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20:5–10.
  • Morio F, Jensen RH, Pape PL, et al. Molecular basis of antifungal drug resistance in yeasts. Int J Antimicrob Agents. 2017. DOI:10.1016/j.ijantimicag.2017.05.012.
  • Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17:e383-e392.
  • Farmakiotis D, Kontoyiannis DP. Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management. Int J Antimicrob Agents. 2017;50:318–324.
  • Arvanitis M, Anagnostou T, Fuchs BB, et al. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014;27:490–526.
  • Tissot F, Lamoth F, Hauser PM, et al. β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med. 2013;188:1100–1109.
  • León C, Ruiz-Santana S, Saavedra P, et al. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions. Crit Care. 2016;20:149.
  • Aittakorpi A, Kuusela P, Koukila-Kähkölä P, et al. Accurate and rapid identification of Candida spp. frequently associated with fungemia by using PCR and the microarray-based Prove-it Sepsis assay. J Clin Microbiol. 2012;50:3635–3640.
  • Tissari P, Zumla A, Tarkka E, et al. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet. 2010;375:224–230.
  • Altun O, Almuhayawi M, Ullberg M, et al. Clinical evaluation of the Filmarray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J Clin Microbiol. 2013;51:4130–4136.
  • Hall L, Le Febre KM, Deml SM, et al. Evaluation of the Yeast Traffic Light PNA FISH probes for identification of Candida species from positive blood cultures. J Clin Microbiol. 2012;50:1446–1448.
  • Radic M, Goic-Barisic I, Novak A, et al. Evaluation of PNA FISH® Yeast Traffic Light in identification of Candida species from blood and non-blood culture specimens. Med Mycol. 2016;54:654–658.
  • Aydemir G, Koç AN, Atalay MA. Evaluation of peptide nucleic acid fluorescent in situ hybridization (PNA FISH) method in the identifi cation of Candida species isolated from blood cultures. Mikrobiyol Bul. 2016;50:293–299.
  • Marschal M, Bachmaier J, Autenrieth I, et al. Evaluation of the accelerate pheno system for fast identification and antimicrobial susceptibility testing from positive blood cultures in bloodstream infections caused by gram-negative pathogens. McAdam AJ, editor. J Clin Microbiol. 2017;55:2116–2126.
  • Gonzalez M, Vong J, Jerris R, et al. Performance of a novel system for rapid identification and susceptibility testing directly from positive paediatric blood cultures. Poster session presented at: American Society for Microbiology (ASM Microbe) Annual Meeting; 2017 Jun 1–5; New Orleans, LA. Available from: http://acceleratediagnostics.com/asm2017.
  • Galiana A, Coy J, Gimeno A, et al. Evaluation of the Sepsis Flow Chip assay for the diagnosis of blood infections. PloS One. 2017;12:e0177627.
  • Babady NE, Miranda E, Gilhuley KA. Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi. J Clin Microbiol. 2011;49:3777–3782.
  • Balada-Llasat J-M, LaRue H, Kamboj K, et al. Detection of yeasts in blood cultures by the Luminex xTAG fungal assay. J Clin Microbiol. 2012;50:492–494.
  • Preuner S, Lion T. Species-specific identification of a wide range of clinically relevant fungal pathogens by the Luminex(®) xMAP technology. Methods Mol Biol. 2013;968:119–139.
  • Tröger B, Härtel C, Buer J, et al. Clinical relevance of pathogens detected by multiplex PCR in blood of very-low-birth weight infants with suspected sepsis - multicentre study of the German neonatal network. PloS One. 2016;11:e0159821.
  • Massire C, Buelow DR, Zhang SX, et al. PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens. J Clin Microbiol. 2013;51:959–966.
  • Gu Z, Hall TA, Frinder M, et al. Evaluation of repetitive sequence PCR and PCR-mass spectrometry for the identification of clinically relevant Candida species. Med Mycol. 2012;50:259–265.
  • Metzgar D, Frinder MW, Rothman RE, et al. The IRIDICA BAC BSI Assay: rapid, sensitive and culture-independent identification of bacteria and Candida in blood. Chaturvedi V, editor. PLoS One. 2016;11:e0158186.
  • Brealey D, Libert N, Pugin J, et al. RADICAL study: rapid diagnosis of suspected bloodstream infections from direct blood testing using PCR/ESI-MS. Crit Care. Internet. 2014;18. cited 2017 Sep 12. Available from: http://ccforum.biomedcentral.com/articles/10.1186/cc14064
  • Nieman AE, Savelkoul PHM, Beishuizen A, et al. A prospective multicenter evaluation of direct molecular detection of blood stream infection from a clinical perspective. BMC Infect Dis. Internet. 2016;16. cited 2017 Sep 12. Available from: http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1646-4
  • Fitting C, Parlato M, Adib-Conquy M, et al. DNAemia detection by multiplex PCR and biomarkers for infection in systemic inflammatory response syndrome patients. PloS One. 2012;7:e38916.
  • Ziegler I, Fagerström A, Strålin K, et al. Evaluation of a commercial multiplex PCR assay for detection of pathogen DNA in blood from patients with suspected sepsis. Minogue TD, editor. PLoS One. 2016;11:e0167883.
  • Divakar K, Lei J, Lee M, et al. High multiplex qPCR platform for rapid detection of fungal pathogens. 112th General Meeting of the American Society for Microbiology (ASM); 2012 Jun 16-19; San Francisco, CA. Available from: http://Aspergillus.org.uk/content/high-multiplex-qpcr-platform-rapid-detection-fungal-pathogens
  • Buchan BW, Ledeboer NA. Emerging technologies for the clinical microbiology laboratory. Clin Microbiol Rev. 2014;27:783–822.
  • Selvarangan R, Bui U, Limaye AP, et al. Rapid identification of commonly encountered Candida species directly from blood culture bottles. J Clin Microbiol. 2003;41:5660–5664.
  • Pryce TM, Palladino S, Price DM, et al. Rapid identification of fungal pathogens in BacT/ALERT, BACTEC, and BBL MGIT media using polymerase chain reaction and DNA sequencing of the internal transcribed spacer regions. Diagn Microbiol Infect Dis. 2006;54:289–297.
  • Wilson DA, Joyce MJ, Hall LS, et al. Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures. J Clin Microbiol. 2005;43:2909–2912.
  • Bidart M, Bonnet I, Hennebique A, et al. An in-house assay is superior to sepsityper for direct matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry identification of yeast species in blood cultures. J Clin Microbiol. 2015;53:1761–1764.
  • Shepard JR, Addison RM, Alexander BD, et al. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol. 2008;46:50–55.
  • Stone NRH, Gorton RL, Barker K, et al. Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact. J Clin Microbiol. 2013;51:1301–1302.
  • Yan Y, He Y, Maier T, et al. Improved identification of yeast species directly from positive blood culture media by combining sepsityper specimen processing and microflex analysis with the matrix-assisted laser desorption ionization biotyper system. J Clin Microbiol. 2011;49:2528–2532.
  • Neely LA, Audeh M, Phung NA, et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med. 2013;5:182ra54.
  • Simner PJ, Uhl JR, Hall L, et al. Broad-range direct detection and identification of fungi by use of the PLEX-ID PCR-electrospray ionization mass spectrometry (ESI-MS) system. J Clin Microbiol. 2013;51:1699–1706.
  • White PL, Hibbitts SJ, Perry MD, et al. Evaluation of a commercially developed semiautomated PCR–surface-enhanced raman scattering assay for diagnosis of invasive fungal disease. J Clin Microbiol. 2014;52:3536–3543.
  • Pfaller MA, Wolk DM, Lowery TJ. T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis. Future Microbiol. 2016;11:103–117.
  • Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60:892–899.
  • Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol. 2011;49:665–670.
  • Nguyen MH, Wissel MC, Shields RK, et al. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;54:1240–1248.
  • León C, Ostrosky-Zeichner L, Schuster M. What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med. 2014;40:808–819.
  • Muñoz P, Giannella M, Fanciulli C, et al. Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2011;17:1538–1545.
  • Lortholary O, Renaudat C, Sitbon K, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010). Intensive Care Med. 2014;40:1303–1312.
  • Beyda ND, Chuang SH, Alam MJ, et al. Treatment of Candida famata bloodstream infections: case series and review of the literature. J Antimicrob Chemother. 2013;68:438–443.
  • Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis Off Publ Infect Dis Soc Am. 2010;50:291–322.
  • Leong C, Buttafuoco A, Glatz M, et al. Antifungal susceptibility testing of Malassezia spp. with an optimized colorimetric broth microdilution method. J Clin Microbiol. 2017;55:1883–1893.
  • Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol. 2004;42:4419–4431.
  • Cornely OA, Bassetti M, Calandra T, et al. Non-neutropenic adult-ESCMID* guideline for the diagnosis and management of Candida diseases 2012. Clin Microbiol Infect. 2012;18:19–37.
  • Hogan D, Shaw C, Martinez M, et al. Evaluation of GenMark’s ePlex ® blood culture identification (BCID) panels. Poster P 1018 presented at: 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); 2017 Apr 22–25; Vienna, Austria.
  • Clancy CJ, Nguyen MH. Diagnostic methods for detection of blood-borne candidiasis. Methods Mol Biol Clifton NJ. 2016;1356:215–238.
  • Clancy CJ, Nguyen MH. Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis Off Publ Infect Dis Soc Am. 2013;56:1284–1292.
  • Afshari A, Schrenzel J, Ieven M, et al. Bench-to-bedside review: rapid molecular diagnostics for bloodstream infection - a new frontier? Crit Care. 2012;16:222.
  • Meyer E, Geffers C, Gastmeier P, et al. No increase in primary nosocomial candidemia in 682 German intensive care units during 2006 to 2011. Euro Surveill. 2013;18(24):pii=20505. DOI: 10.2807/ese.18.24.20505-en
  • Bitar D, Lortholary O, Le Strat Y, et al. Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis. 2014;20:1149–1155.
  • Nunes CZ, Marra AR, Edmond MB, et al. Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection. BMC Infect Dis. 2013;13:486.
  • Maubon D, Hamidfar-Roy R, Courby S, et al. Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J Infect. 2010;61:335–342.
  • Elges S, Arnold R, Liesenfeld O, et al. Prospective evaluation of the SeptiFAST multiplex real-time PCR assay for surveillance and diagnosis of infections in haematological patients after allogeneic stem cell transplantation compared to routine microbiological assays and an in-house real-time PCR method. Mycoses. 2017. DOI:10.1111/myc.12662.
  • Gies F, Tschiedel E, Felderhoff-Müser U, et al. Prospective evaluation of SeptiFast multiplex PCR in children with systemic inflammatory response syndrome under antibiotic treatment. BMC Infect Dis. 2016;16:378.
  • Bloos F, Sachse S, Kortgen A, et al. Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study. PloS One. 2012;7:e46003.
  • Robbins N, Wright GD, Cowen LE. Antifungal drugs: the current armamentarium and development of new agents. Microbiol Spectr. [Internet]. 2016;4. [cited 2017 Sep 6]. Available from: http://www.asmscience.org/content/journal/microbiolspec/10.1128/microbiolspec.FUNK-0002-2016
  • Vallabhaneni S, Cleveland AA, Farley MM, et al. Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008–2014. Open Forum Infect Dis. Internet. 2015;2. cited 2017 Sep 6. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677623/
  • MacVane SH, Nolte FS. Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol. 2016;54:2455–2463.
  • Pardo J, Klinker KP, Borgert SJ, et al. Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel. Diagn Microbiol Infect Dis. 2016;84:159–164.
  • Nelson RE, Stockmann C, Hersh AL, et al. Economic analysis of rapid and sensitive polymerase chain reaction testing in the emergency department for influenza infections in children. Pediatr Infect Dis J. 2015;34:577–582.
  • Schreckenberger PC, McAdam AJ. Point-counterpoint: large multiplex PCR panels should be first-line tests for detection of respiratory and intestinal pathogens. J Clin Microbiol. 2015;53:3110–3115.
  • Jordana-Lluch E, Giménez M, Quesada MD, et al. Evaluation of the broad-range PCR/ESI-MS technology in blood specimens for the molecular diagnosis of bloodstream infections. PloS One. 2015;10:e0140865.
  • Bilir SP, Ferrufino CP, Pfaller MA, et al. The economic impact of rapid Candida species identification by T2Candida among high-risk patients. Future Microbiol. 2015;10:1133–1144.
  • Stevenson M, Pandor A, Martyn-St James M, et al. Sepsis: the LightCycler SeptiFast test MGRADE®, SepsiTestTM and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi - a systematic review and economic evaluation. Health Technol Assess Winch Engl. 2016;20:1–246.
  • Grumaz S, Stevens P, Grumaz C, et al. Next-generation sequencing diagnostics of bacteremia in septic patients. Genome Med. 2016;8. DOI:10.1186/s13073-016-0326-8.
  • Briese T, Kapoor A, Mishra N, et al. Virome capture sequencing enables sensitive viral diagnosis and comprehensive virome analysis. mBio. 2015;6:e01491–15.
  • Minejima E, Wong-Beringer A. Implementation of rapid diagnostics with antimicrobial stewardship. Expert Rev Anti Infect Ther. 2016;14:1065–1075.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.